TuHURA Biosciences, Inc. NV (HURA)
2025-06-30 | ||||
|---|---|---|---|---|
| Interest income | 29,466 | |||
| Grant income | 322,655 | |||
| Total other (expense) income | 352,121 | |||
| Research and development expenses | 4,926,936 | |||
| General and administrative expenses | 4,949,020 | |||
| Operating loss | 9,875,956 | |||
| Net loss | -9,523,835 | |||
| Series a preferred cash dividend | 2,089 | |||
| Net loss attributable to common stockholders | -9,525,924 | |||
| Earnings per share, basic | -0.21 | |||
| Earnings per share, diluted | -0.21 | |||
| Weighted average number of shares outstanding, basic | 44,555,095 | |||
| Weighted average number of shares outstanding, diluted | 44,555,095 | |||